Correspondence to Dr. Irani:

Treating seizures and preventing amnesia in LGI1-antibody encephalitis A new MRI signature? Leucine-rich glioma-inactivated 1 (LGI1)-antibody encephalitis is a treatable disease within the ever-expanding group of autoimmune encephalitides. The illness is typically characterized by the subacute onset of amnesia, confusion, and seizures in middle age, with approximately 60 % of patients showing medial temporal lobe T2 hyperintensities.1,2,e1,e2 The most characteristic seizure syndrome associated with the LGI1 antibody is the recently termed entity of faciobrachial dystonic seizures (FBDS).3–5 FBDS consist of brief, frequent dystonic movements that most commonly affect the arm and ipsilateral hemi